NCT04616248 2026-01-07In Situ Immunomodulation With CDX-301, Radiation Therapy, CDX-1140 and Poly-ICLC in Patients w/ Unresectable and Metastatic Solid TumorsUniversity of Southern CaliforniaPhase 1 Active not recruiting14 enrolled